Compare KDK & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KDK | LAB |
|---|---|---|
| Founded | 2018 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 335.0M | 270.6M |
| IPO Year | 2023 | 2008 |
| Metric | KDK | LAB |
|---|---|---|
| Price | $1.35 | $0.63 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $10.50 | N/A |
| AVG Volume (30 Days) | ★ 5.7M | 865.8K |
| Earning Date | 11-05-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 61.54 |
| EPS | N/A | ★ 0.26 |
| Revenue | $3,797,000.00 | ★ $101,937,000.00 |
| Revenue This Year | $190.07 | N/A |
| Revenue Next Year | $199.16 | N/A |
| P/E Ratio | ★ N/A | $2.53 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.51 | $0.63 |
| 52 Week High | $11.35 | $1.72 |
| Indicator | KDK | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 19.14 | 37.51 |
| Support Level | N/A | $0.63 |
| Resistance Level | $4.14 | $0.79 |
| Average True Range (ATR) | 0.17 | 0.05 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 0.53 | 1.81 |
Kodiak AI Inc is a provider of artificial intelligence (AI)-powered autonomous vehicle technology. This technology addresses the needs of the long-haul trucking, industrial trucking, and defense industries. The company's core offering, the Kodiak Driver, is a single-platform virtual driver that combines advanced AI software with modular hardware for customer deployments. All company operations are conducted in the United States. The company has one operating and reportable segment related to the development of autonomous vehicle technology and related services that can be applied at scale across a broad range of industries and environments.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.